| Product Code: ETC11783586 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Finland continued to rely on imports of creatine kinase, with key suppliers being the USA, Germany, UK, Austria, and New Zealand. Despite a high concentration of imports, the market saw a significant growth rate with a CAGR of 24.17% from 2020 to 2024. However, there was a slight decline in growth from 2023 to 2024 at -20.18%. The competitive landscape remains strong, indicating sustained demand for creatine kinase in Finland.
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 Finland Creatine Kinase Market Overview | 
| 3.1 Finland Country Macro Economic Indicators | 
| 3.2 Finland Creatine Kinase Market Revenues & Volume, 2021 & 2031F | 
| 3.3 Finland Creatine Kinase Market - Industry Life Cycle | 
| 3.4 Finland Creatine Kinase Market - Porter's Five Forces | 
| 3.5 Finland Creatine Kinase Market Revenues & Volume Share, By Test Type, 2021 & 2031F | 
| 3.6 Finland Creatine Kinase Market Revenues & Volume Share, By Application, 2021 & 2031F | 
| 3.7 Finland Creatine Kinase Market Revenues & Volume Share, By Sample Type, 2021 & 2031F | 
| 3.8 Finland Creatine Kinase Market Revenues & Volume Share, By End User, 2021 & 2031F | 
| 3.9 Finland Creatine Kinase Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F | 
| 4 Finland Creatine Kinase Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing prevalence of diseases such as heart attacks, muscular dystrophy, and brain injuries that require monitoring of creatine kinase levels. | 
| 4.2.2 Growing awareness among the Finnish population about the importance of preventive healthcare and regular health check-ups. | 
| 4.2.3 Technological advancements in the healthcare industry leading to the development of more efficient creatine kinase testing methods. | 
| 4.3 Market Restraints | 
| 4.3.1 Stringent regulations and guidelines governing the healthcare industry in Finland, which may impact the introduction of new creatine kinase testing products. | 
| 4.3.2 Limited healthcare budget allocation by the Finnish government, potentially restricting investments in creatine kinase testing infrastructure. | 
| 4.3.3 Competition from alternative diagnostic tests and technologies that may offer quicker or more cost-effective solutions compared to creatine kinase testing. | 
| 5 Finland Creatine Kinase Market Trends | 
| 6 Finland Creatine Kinase Market, By Types | 
| 6.1 Finland Creatine Kinase Market, By Test Type | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 Finland Creatine Kinase Market Revenues & Volume, By Test Type, 2021 - 2031F | 
| 6.1.3 Finland Creatine Kinase Market Revenues & Volume, By Serum Creatine Kinase Test, 2021 - 2031F | 
| 6.1.4 Finland Creatine Kinase Market Revenues & Volume, By CK-MB Test, 2021 - 2031F | 
| 6.1.5 Finland Creatine Kinase Market Revenues & Volume, By CK-MM Test, 2021 - 2031F | 
| 6.2 Finland Creatine Kinase Market, By Application | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 Finland Creatine Kinase Market Revenues & Volume, By Muscle Disorders, 2021 - 2031F | 
| 6.2.3 Finland Creatine Kinase Market Revenues & Volume, By Cardiac Conditions, 2021 - 2031F | 
| 6.2.4 Finland Creatine Kinase Market Revenues & Volume, By Neurological Conditions, 2021 - 2031F | 
| 6.3 Finland Creatine Kinase Market, By Sample Type | 
| 6.3.1 Overview and Analysis | 
| 6.3.2 Finland Creatine Kinase Market Revenues & Volume, By Blood, 2021 - 2031F | 
| 6.3.3 Finland Creatine Kinase Market Revenues & Volume, By Plasma, 2021 - 2031F | 
| 6.3.4 Finland Creatine Kinase Market Revenues & Volume, By Serum, 2021 - 2031F | 
| 6.4 Finland Creatine Kinase Market, By End User | 
| 6.4.1 Overview and Analysis | 
| 6.4.2 Finland Creatine Kinase Market Revenues & Volume, By Hospitals, 2021 - 2031F | 
| 6.4.3 Finland Creatine Kinase Market Revenues & Volume, By Diagnostic Labs, 2021 - 2031F | 
| 6.4.4 Finland Creatine Kinase Market Revenues & Volume, By Research Institutes, 2021 - 2031F | 
| 6.5 Finland Creatine Kinase Market, By Distribution Channel | 
| 6.5.1 Overview and Analysis | 
| 6.5.2 Finland Creatine Kinase Market Revenues & Volume, By Direct Sales, 2021 - 2031F | 
| 6.5.3 Finland Creatine Kinase Market Revenues & Volume, By Online, 2021 - 2031F | 
| 6.5.4 Finland Creatine Kinase Market Revenues & Volume, By Wholesale, 2021 - 2031F | 
| 7 Finland Creatine Kinase Market Import-Export Trade Statistics | 
| 7.1 Finland Creatine Kinase Market Export to Major Countries | 
| 7.2 Finland Creatine Kinase Market Imports from Major Countries | 
| 8 Finland Creatine Kinase Market Key Performance Indicators | 
| 8.1 Average turnaround time for creatine kinase test results. | 
| 8.2 Number of healthcare facilities offering creatine kinase testing services. | 
| 8.3 Rate of adoption of new creatine kinase testing technologies in the Finnish market. | 
| 9 Finland Creatine Kinase Market - Opportunity Assessment | 
| 9.1 Finland Creatine Kinase Market Opportunity Assessment, By Test Type, 2021 & 2031F | 
| 9.2 Finland Creatine Kinase Market Opportunity Assessment, By Application, 2021 & 2031F | 
| 9.3 Finland Creatine Kinase Market Opportunity Assessment, By Sample Type, 2021 & 2031F | 
| 9.4 Finland Creatine Kinase Market Opportunity Assessment, By End User, 2021 & 2031F | 
| 9.5 Finland Creatine Kinase Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F | 
| 10 Finland Creatine Kinase Market - Competitive Landscape | 
| 10.1 Finland Creatine Kinase Market Revenue Share, By Companies, 2024 | 
| 10.2 Finland Creatine Kinase Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |